The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Treating Fabry Patients Having Renal Impairment - EP3630114

The patent EP3630114 was granted to Amicus Therapeutics on Nov 1, 2023. The application was filed on May 30, 2018 under application number EP18733415A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3630114

AMICUS THERAPEUTICS
Application Number
EP18733415A
Filing Date
May 30, 2018
Status
Granted And Under Opposition
Sep 29, 2023
Publication Date
Nov 1, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSJul 31, 2024D YOUNGADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2010113517
DESCRIPTIONUS6274597
DESCRIPTIONUS6583158
DESCRIPTIONUS6589964
DESCRIPTIONUS6599919
DESCRIPTIONUS6916829
DESCRIPTIONUS7141582
DESCRIPTIONUS8592362
INTERNATIONAL-SEARCH-REPORTWO2012154681
OPPOSITIONUS8592362
OPPOSITIONWO2008121826
OPPOSITIONWO2008134628
OPPOSITIONWO2018017721

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents